$180 Million in Medical Research to Improve the Lives of Australians

The Morrison Government is investing $180 million in ground-breaking medical research projects around Australia to improve the lives of Australians and their loved ones.   Funded through the Government’s $20 billion Medical Research Future Fund, 106 medical research projects will receive funding to improve health outcomes, including for Australians with cancer, dementia, brain injuries, heart…

$18.7 Million For Ground-Breaking Stem Cell Research Projects

The Morrison Government is providing $18.7 million to 10 leading research institutions around Australia, to address illnesses facing many Australians and their families, including heart disease, COVID-19, epilepsy and childhood cancer.   The funding will be distributed among 17 projects to further work towards new treatments, diagnostic tools and therapies centred around stem cell use.…

Transcript – Doorstop – Mount Martha

The Hon. Greg Hunt MP Minister for Health and Aged Care   TRANSCRIPT   27 June 2021   DOORSTOP MOUNT MARTHA   E&OE…                       Topics: COVID-19 Vaccine Rollout; Recent COVID cases;   GREG HUNT:          Good afternoon, everybody. I’m joined by Dr Karen Price, the President of the Royal Australian College of General Practitioners. And…

PBS listings to support patients with mesothelioma

From July 1, thousands of Australians and their families suffering from rare cancers and genetic disorders are set to benefit from expanded listings on the Pharmaceutical Benefits Scheme (PBS).   We are expanding the listing for Opdivo® and Yervoy® (nivolumab and ipilimumab), for the treatment of patients with unresectable malignant mesothelioma.   Unresectable malignant mesothelioma…

PBS Listings to Support Patients With Mesothelioma

From July 1, thousands of Australians and their families suffering from rare cancers and genetic disorders are set to benefit from expanded listings on the Pharmaceutical Benefits Scheme (PBS).   We are expanding the listing for Opdivo® and Yervoy® (nivolumab and ipilimumab), for the treatment of patients with unresectable malignant mesothelioma.   Unresectable malignant mesothelioma…